KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Non-Current Deferred Tax Liability (2016 - 2025)

Cvs Health's Non-Current Deferred Tax Liability history spans 17 years, with the latest figure at $3.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Deferred Tax Liability rose 0.68% year-over-year to $3.8 billion, compared with a TTM value of $3.8 billion through Dec 2025, up 0.68%, and an annual FY2025 reading of $3.8 billion, up 0.68% over the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $3.8 billion at Cvs Health, up from $3.5 billion in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $12.3 billion in Q4 2023, with the low at $3.5 billion in Q3 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $5.4 billion, with a median of $4.2 billion recorded in 2023.
  • Year-over-year, Non-Current Deferred Tax Liability surged 89.31% in 2022 and then tumbled 69.09% in 2024.
  • Tracing CVS's Non-Current Deferred Tax Liability over 5 years: stood at $6.3 billion in 2021, then skyrocketed by 89.31% to $11.9 billion in 2022, then grew by 3.73% to $12.3 billion in 2023, then tumbled by 69.09% to $3.8 billion in 2024, then grew by 0.68% to $3.8 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Non-Current Deferred Tax Liability are $3.8 billion (Q4 2025), $3.5 billion (Q3 2025), and $3.6 billion (Q2 2025).